REXULTI FILM-COATED TABLETS 0.25MG
Product details
Registration number: SIN15768P
Classification: Prescription Only
Active ingredients: BREXPIPRAZOLE
Strength: 0.25mg
Dosage form: TABLET, FILM COATED
Route: ORAL
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
ATC code: N05AX16
HSA approval date: 5 August 2019
Manufacturer(s):
- OTSUKA PHARMACEUTICAL CO., LTD. (TOKUSHIMA FACTORY)
- ELAIAPHARM (PRIMARY AND SECONDARY PACKAGER)
- OTSUKA PHARMACEUTICAL CO., LTD. (SECOND TOKUSHIMA FACTORY) (Finished Product Manufacturer)
Manufacturing country/countries: FRANCE; JAPAN
What are the HSA registration number and classification for REXULTI FILM-COATED TABLETS 0.25MG?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN15768P
Classification: Prescription Only
What active ingredients and strength are recorded for REXULTI FILM-COATED TABLETS 0.25MG?
According to the HSA dataset updated 7 August 2026:
Active ingredients: BREXPIPRAZOLE
Strength: 0.25mg
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for REXULTI FILM-COATED TABLETS 0.25MG?
According to the HSA dataset updated 7 August 2026:
Dosage form: TABLET, FILM COATED
Route: ORAL
Who is the recorded registrant for REXULTI FILM-COATED TABLETS 0.25MG?
According to the HSA dataset updated 7 August 2026:
Registrant: OTSUKA PHARMACEUTICALS (SINGAPORE) PTE. LTD.
Which manufacturers and countries are listed for REXULTI FILM-COATED TABLETS 0.25MG?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- OTSUKA PHARMACEUTICAL CO., LTD. (TOKUSHIMA FACTORY)
- ELAIAPHARM (PRIMARY AND SECONDARY PACKAGER)
- OTSUKA PHARMACEUTICAL CO., LTD. (SECOND TOKUSHIMA FACTORY) (Finished Product Manufacturer)
Manufacturing country/countries: FRANCE; JAPAN
Where can I look up REXULTI FILM-COATED TABLETS 0.25MG in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN15768P or the exact product name REXULTI FILM-COATED TABLETS 0.25MG. The general register link does not preselect this product.
What are the source dates for this REXULTI FILM-COATED TABLETS 0.25MG record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this REXULTI FILM-COATED TABLETS 0.25MG record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN15768P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)